Lehigh Valley news. Straight up.

Lilly breaks ground on a $3.5 billion Fogelsville plant for an obesity drug that is not yet approved

Lilly broke ground on a planned $3.5 billion Fogelsville manufacturing site and says it expects 850 permanent jobs.

Fictional engineers and officials with extreme 3D caricature features at a symbolic pharmaceutical plant groundbreaking
Editorial illustration
See the story visuallyLilly’s planned Fogelsville investment

Visual summary

01 / Investment

$3.5 billion facility

$3.5B

Lilly says it broke ground on an injectable medicine manufacturing site in Fogelsville.

02 / Jobs

850 permanent jobs expected

850

Lilly also projects about 2,000 construction jobs while the site is built.

03 / Drug status

Retatrutide is still investigational

Lilly says retatrutide is in Phase 3 trials and cannot legally be sold or marketed for human use.

Want the full context? Read the article ↓

Eli Lilly and Company broke ground Thursday on a $3.5 billion plant in Fogelsville. The drug maker said the site will make shots to treat obesity and more.

Lilly said the plant will create 850 jobs that pay well. It said building the site will also create about 2,000 construction jobs.

The company said it is already hiring in the Lehigh Valley. The jobs include engineers, scientists, lab workers and plant workers.

The plant is expected to open by 2031, Lilly said.

It will make medicines that are given as shots, the company said. One of them is called retatrutide. Lilly is testing it on people with obesity and type 2 diabetes.

The drug is still in late-stage tests, Lilly said. It cannot legally be sold yet. The company said there is no promise it will be approved.

Lilly CEO David A. Ricks said it is one of several new drugs the company is working on.

"This $3.5 billion investment means we'll be able to make these medicines in Pennsylvania for people here at home and around the world," Ricks said.

Lilly said it will give up to $1 million over five years to the Upper Macungie Township Community Fund. The money would pay for a new program at the township's community center. It would focus on healthy food and health help for families.

Jeff Fleischaker chairs the Upper Macungie Township Board of Supervisors. He said township leaders and residents are "excited to welcome Lilly to our community."

Gov. Josh Shapiro called it a "historic, life-changing investment." U.S. Sen. Dave McCormick called it "another major win for Pennsylvania."

Lilly said the site is one of 10 new U.S. plants it has announced since 2020. It is one of four that will make shots and medical devices. The company said the site is part of a $50 billion push to make more medicine in the U.S.

The company said the plant will use automation and artificial intelligence. Lilly also said it is aiming for a top green building rating. That rating is called LEED Gold.

What do you think?

Join the conversation. A nickname is optional; comments are reviewed for spam and safety.

Want more Lehigh Valley news in your Google results? Add Yooumad as a preferred source.